A selective, potent, and orally bioavailable CDK7 inhibitor demonstrates superior anti-cancer activity in colorectal cancer models

被引：0
|
作者：
Park, Heuijoon
Seo, Kyoungwan
Yu, Jihyun
Kim, Jieun
Joo, Min Sung
Kim, Sungeun
Lee, Joonhyung
Lee, Jeonghyeon
Kim, Eun-Jung
Nam, Joonwoo
Han, Wooseok
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-LB168
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB168
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A potent, selective and orally bioavailable small molecule inhibitor of MCL1 for the treatment of cancer
    Matson, Clinton K.
    Kenney, Thomas
    Steiner, Bart H.
    Deodato, Chloe R.
    Yahiaoui, Anella
    Rubio, Claudia A.
    Chan, Julie T.
    Mollova, Nevena
    Keegan, Kathleen S.
    Venkataramani, Chandrasekar
    CANCER RESEARCH, 2022, 82 (12)
  • [22] Identification and preclinical characterization of NMS-P626, a potent, selective and orally bioavailable TrkA inhibitor with anti-tumor activity in a TrkA-dependent colorectal cancer
    Ardini, E.
    Borgia, A. Lombardi
    De Ponti, C.
    Amboldi, N.
    Ballinari, D.
    Saccardo, M. B.
    Magnaghi, P.
    Pesenti, E.
    Isacchi, A.
    Galvani, A.
    EJC SUPPLEMENTS, 2010, 8 (07): : 39 - 40
  • [23] Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Inhibitors of CDK8 for the Treatment of Cancer
    Li, Yangguang
    Liu, Yingtao
    Wu, Jianping
    Liu, Xiaosong
    Wang, Lin
    Wang, Ju
    Yu, Jiaojiao
    Qi, Hongyun
    Qin, Luoheng
    Ding, Xiao
    Ren, Feng
    Zhavoronkov, Alex
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (08) : 5439 - 5452
  • [24] SY-1365, a potent and selective CDK7 inhibitor, exhibits promising anti-tumor activity in multiple preclinical models of aggressive solid tumors
    Hu, Shanhu
    Ke, Nan
    Ren, Yixuan
    Miljovska, Sofija
    Rajagopal, Nisha
    McKeown, Michael
    Orlando, David
    Sprott, Kevin
    Choi, Yoon J.
    Olson, Eric
    Fritz, Christian C.
    CANCER RESEARCH, 2017, 77
  • [25] Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
    Kwiatkowski, Nicholas
    Zhang, Tinghu
    Rahl, Peter B.
    Abraham, Brian J.
    Reddy, Jessica
    Ficarro, Scott B.
    Dastur, Anahita
    Amzallag, Arnaud
    Ramaswamy, Sridhar
    Tesar, Bethany
    Jenkins, Catherine E.
    Hannett, Nancy M.
    McMillin, Douglas
    Sanda, Takaomi
    Sim, Taebo
    Kim, Nam Doo
    Look, Thomas
    Mitsiades, Constantine S.
    Weng, Andrew P.
    Brown, Jennifer R.
    Benes, Cyril H.
    Marto, Jarrod A.
    Young, Richard A.
    Gray, Nathanael S.
    NATURE, 2014, 511 (7511) : 616 - +
  • [26] Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
    Nicholas Kwiatkowski
    Tinghu Zhang
    Peter B. Rahl
    Brian J. Abraham
    Jessica Reddy
    Scott B. Ficarro
    Anahita Dastur
    Arnaud Amzallag
    Sridhar Ramaswamy
    Bethany Tesar
    Catherine E. Jenkins
    Nancy M. Hannett
    Douglas McMillin
    Takaomi Sanda
    Taebo Sim
    Nam Doo Kim
    Thomas Look
    Constantine S. Mitsiades
    Andrew P. Weng
    Jennifer R. Brown
    Cyril H. Benes
    Jarrod A. Marto
    Richard A. Young
    Nathanael S. Gray
    Nature, 2014, 511 : 616 - 620
  • [27] OKI-1546 is a selective, orally bioavailable inhibitor of CDK12 that causes tumor regression in multiple preclinical cancer models
    Strait, Alexander A.
    Mareska, David A.
    Mahadevan, Jyothi
    Schulte, Christie A.
    Izrayelit, Yevgeniy
    Boys, Mark L.
    Woessner, Richard
    CANCER RESEARCH, 2023, 83 (07)
  • [28] Preclinical evaluation of intermittent dosing regimens on antitumor and PD activity of SY-5609, a potent and selective oral CDK7 inhibitor, in ovarian cancer xenografts
    Johannessen, L.
    Dworakowski, W.
    Sawant, P.
    Ke, N.
    Lefkovith, A.
    D'Ippolito, A.
    Eaton, M.
    Henry, S. H.
    Hodgson, G.
    ANNALS OF ONCOLOGY, 2021, 32 : S365 - S365
  • [29] AB474, a potent orally bioavailable inhibitor of arginase, for the treatment of cancer
    Eckard, Sterling C.
    Chen, Yu
    Piovesan, Dana
    Narasappa, Nell
    Park, Timothy W.
    Kalisiak, Jarek
    Newcomb, Eric T.
    Leleti, Manmohan R.
    Soni, Divyank
    Ginn, Elaine
    Chen, Jie
    DiRenzo, Dan
    Zhang, Kristen
    Jin, Lixia
    Young, Stephen W.
    Walters, Matthew J.
    Schindler, Ulrike
    Powers, Jay P.
    CANCER RESEARCH, 2019, 79 (13)
  • [30] Discovery of a Novel Macrocyclic Noncovalent CDK7 Inhibitor for Cancer Therapy
    Lu, Hongfu
    Zhang, Yihong
    Liu, Jinxin
    Jiang, Tao
    Yu, Xiang
    Zhang, Haoyu
    Liang, Tao
    Peng, Jingjing
    Cai, Xin
    Lan, Xiaoling
    Ren, Jinmin
    Ge, Mei
    Zhang, Jingyang
    Shang, Jingjin
    Yu, Jiaojiao
    Ren, Hongcan
    Liu, Qiang
    Gao, Jinting
    Tang, Lili
    Ding, Xiao
    Zhang, Man
    Aliper, Alex
    Lu, Qiang
    Zhou, Fusheng
    Lan, Jiong
    Ren, Feng
    Zhavoronkov, Alex
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (22) : 20580 - 20594
12345